Daiichi Sankyo Company, Limited (DSKYF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 01:42PM EDT. Market open.
| Previous Close | 36.22 |
| Open | 35.08 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 34.57 - 35.21 |
| 52 Week Range | 23.45 - 37.91 |
| Volume | |
| Avg. Volume | 22,967 |
| Market Cap | 67.17B |
| Beta (5Y Monthly) | 0.29 |
| PE Ratio (TTM) | 51.51 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.39 (1.07%) |
| Ex-Dividend Date | Sept 27, 2024 |
| 1y Target Est | N/A |
- Yahoo Finance
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
- Zacks
Atossa (ATOS) Reports Positive Results From EVANGELINE Study
Atossa (ATOS) unveils positive results from its phase 2 EVANGELINE clinical study, which shows that (Z)-endoxifen can reduce the growth of ER+ breast cancer.
- Zacks
Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised)
Merck's (MRK) phase II/III study called REJOICE-Ovarian01 study will evaluate the efficacy of raludotatug deruxtecan in patients with platinum-resistant ovarian cancer.
© 2024 Yahoo. All rights reserved.